FDA Reviewing Osteoporosis Drugs for Esophageal Cancer Risk
FDA Reviewing Osteoporosis Drugs for Esophageal Cancer Risk Bloomberg
View ArticleBone drug tied to lower colon cancer risk
Bone drug tied to lower colon cancer risk Yahoo/Reuters
View ArticleUS judge narrows benchmark Fosamax case vs. Merck
US judge narrows benchmark Fosamax case vs. Merck Reuters
View ArticleBone Drugs Need Label Changes on Use Duration, Panel Says
Bone Drugs Need Label Changes on Use Duration, Panel Says Bloomberg
View ArticleMerck says it won its 5th Fosamax lawsuit
Merck says it won its 5th Fosamax lawsuit Yahoo/AP
View ArticleMerck loses 'bellwether' Fosamax case
Merck loses 'bellwether' Fosamax case Fierce Pharma
View ArticleMerck Hid Fosamax’s Bone-Weakening Risks, Lawyer Contends
Merck Hid Fosamax’s Bone-Weakening Risks, Lawyer Contends Bloomberg
View ArticleMerck’s Fosamax on Trial Again After First Case Halted
Merck’s Fosamax on Trial Again After First Case Halted Bloomberg
View ArticleMerck Starts Fresh Trial on Fosamax Broken-Leg Claims
Merck Starts Fresh Trial on Fosamax Broken-Leg Claims Bloomberg
View ArticleMerck Says Jury Rules in Its Favor in Fosamax Trial
Merck Says Jury Rules in Its Favor in Fosamax Trial Bloomberg
View ArticleA Preemption Comeback? Merck Wins An Important Ruling
A Preemption Comeback? Merck Wins An Important Ruling Pharmalot
View ArticleWhat Liability? Merck Wins A Key Ruling That Bolsters Pharma Comment Now...
What Liability? Merck Wins A Key Ruling That Bolsters Pharma Comment Now Follow Comments Forbes
View ArticleHundreds of Fosamax lawsuits vs. Merck ordered readied for trial
Hundreds of Fosamax lawsuits vs. Merck ordered readied for trial Reuters
View ArticleJudge makes rare move in Merck Fosamax litigation
Judge makes rare move in Merck Fosamax litigation Fierce Pharma
View ArticleMerck agrees to settle litigation over Fosamax jaw injuries
Merck agrees to settle litigation over Fosamax jaw injuries Yahoo/Reuters
View ArticleAmgen Vs. Merck, Lilly In Osteoporosis Competition
Amgen Vs. Merck, Lilly In Osteoporosis Competition Seeking Alpha
View Article
